Target- |
MechanismImmunomodulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date23 Aug 2017 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date29 Dec 1982 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date09 Mar 1959 |
100 Clinical Results associated with Link Medical Products Pty Ltd.
0 Patents (Medical) associated with Link Medical Products Pty Ltd.
100 Deals associated with Link Medical Products Pty Ltd.
100 Translational Medicine associated with Link Medical Products Pty Ltd.